Initial Workup for Urinary Retention in Adult Males

History and Symptom Assessment

The American Urological Association recommends obtaining a detailed medical history focusing on the nature and duration of genitourinary symptoms, previous surgical procedures affecting the genitourinary tract, general health issues, sexual function history, and current medications 1
Assess for lower urinary tract symptoms (LUTS) including decreased urinary stream, incomplete bladder emptying, urinary tract infections, epididymitis, and decreased force of ejaculation 2
Evaluate for symptoms of obstruction such as hesitancy, intermittency, straining, and weak stream 3
Document the frequency, time of day, course of symptoms, and relationship to environmental changes 4
Use a standardized questionnaire like the International Prostate Symptom Score (IPSS) to quantitatively assess symptoms and bother 3, 5

Perform a focused physical examination with emphasis on the genitourinary system 3, 5
Conduct a digital rectal examination (DRE) to evaluate anal sphincter tone and the prostate gland (size, consistency, shape, and abnormalities) 1
Assess the suprapubic area to rule out bladder distention 1
Evaluate overall motor and sensory function focused on the perineum and lower limbs 1

Perform urinalysis using dipstick tests to check for hematuria, proteinuria, pyuria, or other pathological findings 3, 1
Measure post-void residual (PVR) volume through bladder scanning or straight catheterization 6
Consider serum PSA testing after discussing the benefits and risks with the patient, particularly if life expectancy is greater than 10 years and if diagnosis of prostate cancer would modify management 1
For suspected urethral stricture, perform urethrocystoscopy or retrograde urethrogram (RUG) 6, 2

Provide immediate bladder decompression via urethral catheterization for relief of acute urinary retention 6
Consider using silver alloy-coated urinary catheters to reduce urinary tract infection risk 6
Administer an alpha blocker (e.g., tamsulosin or alfuzosin) prior to attempting catheter removal to improve chances of successful voiding trial 6
Remove indwelling catheters as soon as medically possible, ideally within 24-48 hours, to minimize infection risk 6

Patients should be evaluated 4-12 weeks after initiating treatment (provided adverse events don't require earlier consultation) 5
Reevaluation should include the IPSS and may include post-void residual measurement and uroflowmetry 5
Patients who successfully void after catheter removal should be informed that they remain at increased risk for recurrent urinary retention 6
Consider referral for urologic evaluation if symptoms persist or recur 3, 5

Uroflowmetry may be used in the initial and ongoing evaluation of patients with lower urinary tract symptoms (LUTS) that suggest an abnormality of voiding/emptying, as significant abnormalities in uroflow indicate dysfunction in the voiding phase of micturition, although it is limited by inability to distinguish between low flow due to outlet obstruction, bladder underactivity, or both 7
The American Urological Association recommends that urodynamic studies, including multi-channel filling cystometry, may be performed when it is important to determine if detrusor overactivity or other abnormalities of bladder filling/urine storage are present, and should not be routinely performed in the initial evaluation unless diagnostic uncertainty exists 7, 8

Ultrasound of the kidney and bladder can identify hydronephrosis, duplex renal system, or other anatomical abnormalities, according to the American College of Radiology 9
The use of silver alloy-coated urinary catheters can reduce urinary tract infection risk, as suggested by the American Heart Association 10

Relying on a single post-void residual (PVR) measurement is not recommended, as values can fluctuate, and PVR volume measurement is essential for diagnosis and monitoring 7
Performing unnecessary invasive testing, such as urodynamics or cystoscopy, when not indicated by clinical presentation, should be avoided, as recommended by the American Urological Association 7, 8

The American Urological Association recommends initiating an alpha-blocker (tamsulosin 0.4 mg or alfuzosin) at the time of catheter insertion to improve the likelihood of successful voiding trial after catheter removal, with a moderate strength of evidence 11
In patients with refractory retention who fail at least one attempt at catheter removal, surgery is recommended for those who are acceptable surgical candidates, according to The Journal of Urology 11

Refer urgently to urology for refractory retention failing catheter removal attempts, as recommended by The Journal of Urology 11